NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Research Report: Nippon AMC

Key Highlights

  • Nippon AMC (NAM) reported a market share of 8.7% in QAAUM, a five-year high, driven by steady net inflows, robust SIP momentum, and a favorable equity mix of 47% in Dec'25.
  • NAM's FY26YTD equity share accretion reached 7.1%, the highest in the industry, with a year-over-year increase of 11 basis points.

Financial Performance

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

  • NAM's blended yields remained stable at 37 basis points in 3Q, with equity yields at 53 basis points, despite a rise in passive contribution.
  • Management expects annual compression of 1-2 basis points due to telescopic pricing, which will be offset by diversified retail flows, SIP growth, and product innovation.

Industry Leadership

  • NAM has the largest retail investor base of 22.7 million, accounting for 38.4% of the industry share, underpinned by a highly granular SIP book of INR1.7 trillion.
  • The company's ETF platform, with INR2.1 trillion AUM, anchors passive leadership, with a market share of ~20% and dominant folio share of 48%.

Outlook

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

  • We expect Nippon AMC to deliver a compound annual growth rate (CAGR) of:
    • 16% in revenue over FY26-28E
    • 17% in EBITDA over FY26-28E
    • 18% in core profit after tax (PAT) over FY26-28E
  • We reiterate a BUY rating on the stock with a target price of INR1,040, premised on 38x core FY28E earnings.

Investor Takeaway

Investors may consider buying Nippon AMC based on Motilal Oswal's positive recommendation.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.